Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization (Q46222232)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

title

Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

main subject

myopia

1 reference

based on heuristic

inferred from title

neovascularization

1 reference

based on heuristic

inferred from title

author name string

Lazaros Konstantinidis

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

Irmela Mantel

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

Jean-Antoine C Pournaras

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

Leonidas Zografos

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

Aude Ambresin

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

publication date

29 November 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

published in

Graefe's Archive for Clinical and Experimental Ophthalmology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

volume

247

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

page(s)

311-318

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

cites work

Natural History of Choroidal Neovascularization in Degenerative Myopia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00417-008-0995-0

retrieved

21 January 2018

Etiology of choroidal neovascularization in young patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00417-008-0995-0

retrieved

21 January 2018

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00417-008-0995-0

retrieved

21 January 2018

Proper Method for Calculating Average Visual Acuity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab for the treatment of neovascular age-related macular degeneration: a review

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective occlusion of subfoveal choroidal neovascularization in pathologic myopia using a new technique of ingrowth site treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of choroidal neovascularization in high myopia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective occlusion of subfoveal choroidal neovascularization in pathologic myopia using a new technique of ingrowth site treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual Prognosis of Disciform Degeneration in Myopia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of intravitreal ranibizumab (Lucentis).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Visual Outcome of Choroidal Neovascularization in Pathologic Myopia: Natural History and Laser Treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of exudative age-related macular degeneration: many factors to consider

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab for neovascular age-related macular degeneration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy for subfoveal neovascularisation associated with pathological myopia: a pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marginal crack after intravitreal bevacizumab for myopic choroidal neovascularization

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-year results of macular translocation with scleral infolding in myopic choroidal neovascularisation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19043731

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00417-008-0995-0

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

PubMed publication ID

19043731

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19043731

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19043731

ResearchGate publication ID

23556692

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46222232&oldid=2207726675"